News tagged with adverse events
Related topics: patients , food and drug administration , clinical trials
Natalizumab shows promise for teens with multiple sclerosis
(HealthDay)—Natalizumab may be safe in pediatric multiple sclerosis (MS) patients with highly active disease, according to a small study published online Feb. 18 in JAMA Neurology.
Neuroscience
Feb 22, 2013 |
5 / 5 (3) |
0
Supplement mixture improves memory in mild Alzheimer's
(HealthDay) -- A supplement mixture (Souvenaid) containing dietary precursors and specific nutrients can improve memory in drug-naive patients with mild Alzheimer's disease (AD), according to a study published ...
Alzheimer's disease & dementia
Jul 12, 2012 |
4 / 5 (3) |
1
|
Landmark editorial denounces 'poor publication practices' in spine research
Loyola University Hospital spine surgeon Dr. Alexander Ghanayem is co-author of a landmark editorial challenging the integrity of published industry-sponsored research involving a bone-growth product.
Other
Jun 28, 2011 |
5 / 5 (2) |
0
Benefits of radionuclide therapy for neuroendocrine tumors
According to new Dutch research featured in the September issue of The Journal of Nuclear Medicine, a peptide receptor radiolabeled therapy (PRRT), [177Lu-DOTA0,Tyr3]Octreotate (177Lu-octreotate) , is effective not only i ...
Cancer
Sep 20, 2011 |
5 / 5 (2) |
1
Commentary: Drug companies must report clinical trial results, even when they won't lead to a product
Drug companies sponsoring human trials of possible new medications have ethical responsibilities to study participants and to science to disclose the results of their clinical research -- even when product development is ...
Medications
Sep 28, 2011 |
5 / 5 (2) |
1
|
Hospital patients suffer in shift shuffle
Patient handovers have increased significantly as a result of the restrictions on the number of hours residents are allowed to work. Multiple shift changes, and resulting consecutive sign-outs, during patient handovers are ...
Other
Oct 20, 2011 |
5 / 5 (2) |
0
First US embryonic stem cell trial is halted
The first-ever trial using human embryonic stem cells to treat paralysis has been halted due to high costs and the company will focus instead on new cancer treatments, Geron said Tuesday.
Medical research
Nov 15, 2011 |
2.5 / 5 (4) |
2
Monthly shot lowers cholesterol 66 percent: study
A monthly injection of an experimental drug made by the US biotech firm Amgen reduced patients' cholesterol by up to 66 percent, according to a small study described at a US cardiology conference.
Cardiology
Mar 26, 2012 |
5 / 5 (2) |
5
Topical treatment shows potential for infantile eczema
(HealthDay) -- Ten days of treatment with a cream containing 15(R/S)-methyl-lipoxin A4 (LXA4) is well tolerated and reduces the severity of infantile eczema, according to a study published online July 26 in the ...
Diseases, Conditions, Syndromes
Aug 08, 2012 |
5 / 5 (2) |
0
Use of adjunctive antipsychotic medications in depression
A study published this week in PLOS Medicine finds that while antipsychotic medications are associated with small-to-moderate improvements in depressive symptoms in adults, there is little evidence for improvement on mea ...
Psychology & Psychiatry
Mar 12, 2013 |
5 / 5 (2) |
0
Statins are unlikely to prevent blood clots, analysis finds
Despite previous studies suggesting the contrary, statins (cholesterol-lowering drugs) may not prevent blood clots (venous thrombo-embolism) in adults, according to a large analysis by international researchers published ...
Cardiology
Sep 18, 2012 |
3 / 5 (2) |
1
|
For some surgeries, more is better when choosing hospitals
Are you scheduled for heart bypass surgery or weight loss surgery? You might want to find out just how frequently different hospitals in your area are performing those procedures before deciding where to go. ...
Other
Sep 01, 2011 |
5 / 5 (1) |
0
Childhood traumatic experiences associated with adult IBS symptoms
Patients with irritable bowel syndrome (IBS) have a significantly greater prevalence of early adverse life events , including general trauma as well as physical, emotional and sexual abuse, according to a new study in Clinical Ga ...
Diseases, Conditions, Syndromes
Mar 29, 2012 |
5 / 5 (1) |
0
A common cholesterol medication may impact kidney health
Older patients taking a common cholesterol medication should be cautious of the impact on their kidney health. In a new study by Dr. Amit Garg, Scientist at the Lawson Health Research Institute and the Institute for Clinical ...
Diseases, Conditions, Syndromes
Apr 17, 2012 |
5 / 5 (1) |
0
Phase I study of temsirolimus, capecitabine proves safe; positive survival trend seen
A phase I clinical trial examining the safety of combining temsirolimus and capecitabine in advanced malignancies suggests the two agents can be given safely to patients. In addition, the Georgetown Lombardi Comprehensive ...
Cancer
May 16, 2012 |
5 / 5 (1) |
0
